Lista de obras -

1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation

151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old

1718Resistance among Invasive Group A Streptococcal Infections, United States, 1999-2012.

artículo científico publicado en 2014

647Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States.

artículo científico publicado en 2014

A Cluster of Group A Streptococcal Infections in a Skilled Nursing Facility-the Potential Role of Healthcare Worker Presenteeism

artículo científico publicado en 2016

A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction

scientific article published in 2023

A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa

artículo científico publicado en 2020

An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States

artículo científico publicado en 2012

Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study

artículo científico publicado en 2016

Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience ⬇️

artículo científico publicado en 2008

Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997-2014

artículo científico publicado en 2020

Clonal Distribution of Invasive Pneumococcal Isolates from Children and Selected Adults in the United States Prior to 7-Valent Conjugate Vaccine Introduction ⬇️

artículo científico publicado en 2005

Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction ⬇️

artículo científico publicado en 2003

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.

artículo científico publicado en 2017

Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States

artículo científico publicado en 2019

Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia

artículo científico publicado en 2013

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

artículo científico publicado en 2015

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

artículo científico publicado en 2006

Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States

artículo científico publicado en 2002

Emergent Invasive Group A Streptococcus dysgalactiae subsp. equisimilis, United States, 2015-2018 ⬇️

artículo científico publicado en 2019

Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance

scholarly article by Srinivas Acharya Nanduri et al published 14 January 2019 in JAMA Pediatrics

Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.

artículo científico publicado en 2016

Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016

Epidemiology of Invasive Pneumococcal Disease Among High-Risk Adults Since the Introduction of Pneumococcal Conjugate Vaccine for Children ⬇️

artículo científico publicado el 15 de noviembre de 2012

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

artículo científico publicado en 2002

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape

artículo científico publicado en 2014

Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States ⬇️

artículo científico publicado en 2009

Genomic Epidemiology of Penicillin-Nonsusceptible Pneumococci with Nonvaccine Serotypes Causing Invasive Disease in the United States.

artículo científico publicado en 2017

Genotypes of invasive pneumococcal isolates recently recovered from Italian patients

artículo científico publicado en 2002

Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States

artículo científico publicado en 2011

Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci

artículo científico publicado en 2018

High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction

artículo científico publicado en 2016

Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans

artículo científico publicado en 2003

Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States

scientific article published in 2022

Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities ⬇️

artículo científico publicado en 2011

In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae

artículo científico publicado en 2008

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

artículo científico publicado en 2007

Increase in Invasive Group A Streptococcal Disease and Emergence of Mucoid Strains in a Pediatric Population: February-June 2017

artículo científico publicado en 2019

Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States ⬇️

artículo científico publicado en 2005

Invasive Group A Streptococcal Infections Among People Who Inject Drugs and People Experiencing Homelessness in the United States, 2010-2017

artículo científico publicado en 2020

Invasive Pneumococcal Disease Clusters Disproportionally Impact Persons Experiencing Homelessness, Injecting Drug Users, and the Western United States

scientific article published in 2022

Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003

artículo científico publicado en 2007

Invasive group a streptococcal disease in nursing homes, Minnesota, 1995-2006.

artículo científico publicado en 2008

Invasive pneumococcal strain distributions and isolate clusters associated with persons experiencing homelessness during 2018

artículo científico publicado en 2020

Investigation of a prolonged Group A Streptococcal outbreak among residents of a skilled nursing facility, Georgia, 2009-2012.

artículo científico publicado en 2013

Key features of invasive pneumococcal isolates recovered in Lima, Peru determined through whole genome sequencing ⬇️

artículo científico publicado en 2017

Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine ⬇️

scientific article published on September 2004

Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017 ⬇️

artículo científico publicado en 2020

Outbreak of invasive infections from subtype emm26.3 group A Streptococcus among homeless adults-Anchorage, Alaska, 2016-2017.

artículo científico publicado en 2017

Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains

artículo científico publicado en 2008

Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016

scientific article published on 13 February 2020

Pneumococcal capsular switching: a historical perspective

artículo científico publicado en 2012

Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010

artículo científico publicado en 2017

Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005

scientific article published in 2008

Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015. ⬇️

artículo científico publicado en 2017

Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. ⬇️

artículo científico publicado en 2014

Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B.

artículo científico publicado en 2009

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002 ⬇️

artículo científico publicado en 2006

Prevalence of first-step mutants among levofloxacin-susceptible invasive isolates of Streptococcus pneumoniae in the United States ⬇️

artículo científico publicado en 2006

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

artículo científico publicado en 2016

Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines

artículo científico publicado en 2011

Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009.

artículo científico publicado en 2014

Seasonal, Geographic, and Temporal Trends of emm Clusters Associated With Invasive Group A Streptococcal Infections in US Multistate Surveillance

artículo científico publicado en 2017

Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden

artículo científico publicado en 2012

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

artículo científico publicado en 2010

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004

artículo científico publicado en 2007

The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success

artículo científico publicado en 2012

The role of interspecies recombination in the evolution of antibiotic-resistant pneumococci

artículo científico publicado en 2021

Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period

artículo científico publicado en 2012

Variable recombination dynamics during the emergence, transmission and 'disarming' of a multidrug-resistant pneumococcal clone

artículo científico publicado en 2014

Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates

scientific article published on 30 April 2020

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

artículo científico publicado en 2009

Lista de obras de

1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation

151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old

1718Resistance among Invasive Group A Streptococcal Infections, United States, 1999-2012.

647Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States.

A Cluster of Group A Streptococcal Infections in a Skilled Nursing Facility-the Potential Role of Healthcare Worker Presenteeism

A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction

A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa

An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States

Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study

Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience ⬇️

Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997-2014

Clonal Distribution of Invasive Pneumococcal Isolates from Children and Selected Adults in the United States Prior to 7-Valent Conjugate Vaccine Introduction ⬇️

Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction ⬇️

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.

Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States

Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States

Emergent Invasive Group A Streptococcus dysgalactiae subsp. equisimilis, United States, 2015-2018 ⬇️

Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance

Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.

Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016

Epidemiology of Invasive Pneumococcal Disease Among High-Risk Adults Since the Introduction of Pneumococcal Conjugate Vaccine for Children ⬇️

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape

Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States ⬇️

Genomic Epidemiology of Penicillin-Nonsusceptible Pneumococci with Nonvaccine Serotypes Causing Invasive Disease in the United States.

Genotypes of invasive pneumococcal isolates recently recovered from Italian patients

Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States

Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci

High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction

Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans

Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States

Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities ⬇️

In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Increase in Invasive Group A Streptococcal Disease and Emergence of Mucoid Strains in a Pediatric Population: February-June 2017

Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States ⬇️

Invasive Group A Streptococcal Infections Among People Who Inject Drugs and People Experiencing Homelessness in the United States, 2010-2017

Invasive Pneumococcal Disease Clusters Disproportionally Impact Persons Experiencing Homelessness, Injecting Drug Users, and the Western United States

Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003

Invasive group a streptococcal disease in nursing homes, Minnesota, 1995-2006.

Invasive pneumococcal strain distributions and isolate clusters associated with persons experiencing homelessness during 2018

Investigation of a prolonged Group A Streptococcal outbreak among residents of a skilled nursing facility, Georgia, 2009-2012.

Key features of invasive pneumococcal isolates recovered in Lima, Peru determined through whole genome sequencing ⬇️

Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine ⬇️

Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017 ⬇️

Outbreak of invasive infections from subtype emm26.3 group A Streptococcus among homeless adults-Anchorage, Alaska, 2016-2017.

Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains

Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016

Pneumococcal capsular switching: a historical perspective

Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010

Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005

Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015. ⬇️

Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. ⬇️

Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B.

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002 ⬇️

Prevalence of first-step mutants among levofloxacin-susceptible invasive isolates of Streptococcus pneumoniae in the United States ⬇️

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines

Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009.

Seasonal, Geographic, and Temporal Trends of emm Clusters Associated With Invasive Group A Streptococcal Infections in US Multistate Surveillance

Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004

The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success

The role of interspecies recombination in the evolution of antibiotic-resistant pneumococci

Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period

Variable recombination dynamics during the emergence, transmission and 'disarming' of a multidrug-resistant pneumococcal clone

Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis